Fibromyalgia and the Gut Microbiome: Current Evidence, Mechanistic Insights, and Research Priorities

Fibromyalgia (FM) is a chronic condition characterized by widespread musculoskeletal pain, frequently accompanied by fatigue, sleep disturbances, and cognitive dysfunction. Studies have identified differences in gut microbial composition and metabolite profiles in some FM cohorts, but their consistency, clinical significance, and causal direction remain uncertain. This critical narrative review evaluates human observational evidence, experimental models, and microbiome-targeted interventions, distinguishing findings directly relevant to FM from mechanistic insights derived from other conditions. Particular attention is given to short-chain fatty acids (SCFAs), tryptophan metabolism, and bile acids as potential mediators of host–microbiome interactions along the gut–brain axis. Human studies are limited by small, predominantly female cohorts, inconsistent findings, and confounding related to gastrointestinal conditions, diet, medication use, and intestinal transit. Although transfer of FM-associated microbiota can induce pain-related phenotypes in experimental animals, these findings do not establish disease causation in humans. Evidence for dietary interventions, probiotics, and fecal microbiota transplantation remains preliminary, with unresolved questions concerning efficacy, safety, and durability. We also propose a hypothetical framework of overlapping immune, metabolic, and neuroendocrine or stress-related domains to guide future investigation, not to define validated FM endotypes. Multi-omics and artificial intelligence (AI) may help test these hypotheses, but clinical applications require longitudinal research, independent validation, and adequately controlled trials.

Authors

Institutions

Publication Details

Journal
Microorganisms
Published
2026-11-12
DOI
https://doi.org/10.3390/microorganisms14112626
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Fibromyalgia and the Gut Microbiome: Current Evidence, Mechanistic Insights, and Research Priorities

Edda Russo
Microorganisms
Gut microbiota and health
article

Fibromyalgia and the Gut Microbiome: Current Evidence, Mechanistic Insights, and Research Priorities

Edda Russo
article en

Abstract

Fibromyalgia (FM) is a chronic condition characterized by widespread musculoskeletal pain, frequently accompanied by fatigue, sleep disturbances, and cognitive dysfunction. Studies have identified differences in gut microbial composition and metabolite profiles in some FM cohorts, but their consistency, clinical significance, and causal direction remain uncertain. This critical narrative review evaluates human observational evidence, experimental models, and microbiome-targeted interventions, distinguishing findings directly relevant to FM from mechanistic insights derived from other conditions. Particular attention is given to short-chain fatty acids (SCFAs), tryptophan metabolism, and bile acids as potential mediators of host–microbiome interactions along the gut–brain axis. Human studies are limited by small, predominantly female cohorts, inconsistent findings, and confounding related to gastrointestinal conditions, diet, medication use, and intestinal transit. Although transfer of FM-associated microbiota can induce pain-related phenotypes in experimental animals, these findings do not establish disease causation in humans. Evidence for dietary interventions, probiotics, and fecal microbiota transplantation remains preliminary, with unresolved questions concerning efficacy, safety, and durability. We also propose a hypothetical framework of overlapping immune, metabolic, and neuroendocrine or stress-related domains to guide future investigation, not to define validated FM endotypes. Multi-omics and artificial intelligence (AI) may help test these hypotheses, but clinical applications require longitudinal research, independent validation, and adequately controlled trials.

MicroorganismsVol. 14(11)
Ospedale San Giuseppe (IT), Azienda Usl Toscana Centro (IT)
Good health and well-being
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon